PARP Inhibitors in the Management of Ovarian Cancer
ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!
Stage III-IV EOC*
Bevacizumab
maintenance
Chemotherapy
Chemotherapy ±
bevacizumab
Chemotherapy
End second-line
therapy
Platinum resistant
recurrence
treatment PARPi maintenance OR
PARPi treatment for
germline or somatic
BRCAm
OR
